Raffles Medical set to profit from the opening of SIngapore’s borders - RHB

The company is the sole provider of Covid-19 PCR tests for Changi Airport.

Raffles Medical is expected to benefit from the reopening of Singapore’s borders, according to a report released by RHB.

Following yesterday’s announcement that Singapore has added nine countries to the Vaccine Travel Lane (VTL), up to 3,000 passengers from a total of 11 nations are expected to enter Singapore daily. With Raffles Medical as the only provider of Covid-19 PCR tests for Changi Airport, RHB expects this to work in the company’s favor.

The conversion of the Connect@Changi facility into a dedicated treatment facility is also expected to support near-term revenue growth.

Also supporting this is the return of both local and foreign patients to its clinics, as well as the breaking even of the Chongqing hospital in 2022F.

Overall, RHB expects these to positively influence next year’s earnings.

Follow the links for more news on

Raffles Medical Group

reopening

vaccinated travel lane

Also Read

Singaporeans' physical well-being at highest level since 2019

SingHealth partners with OutcomesAI to integrate AI into medical workflows

Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

I want to download the media kit